Anyone voting, don’t forget to click onto your emails to make the vote count. While the ideal would be no increase there needs to be a delay. We demand the government to step in. 

Eli Lilly, the manufacturer of Mounjaro, has announced a staggering 170% increase in the price of this critical medication, a move that stands to severely impact the 1.5 million private prescription users in the UK. This unforeseen hike is not only financially burdensome but also poses a significant health risk, as Mounjaro requires patients to titrate up and down rather than stop using it suddenly.

This abrupt increase doesn't consider the plight of patients who have come to rely on Mounjaro for their healthcare needs. Many patients on private prescriptions have not been given sufficient notice to make informed decisions about their treatment. This lack of a reasonable adjustment period sets a worrying precedent for future pharmaceutical pricing practices in the UK.

Eli Lilly's decision threatens the health and financial stability of countless individuals. It's crucial that the government intervene to delay this price increase, providing patients the time needed to adjust their prescriptions and explore feasible alternatives. Such measures are vital in safeguarding the health outcomes of Mounjaro users, ensuring they do not face sudden disruptions in their treatment regimen due to financial barriers.

We urge the UK Government and Eli Lilly to consider the ramifications this price hike could have on a vulnerable population, and prioritize the health and well-being of UK citizens. Please lend your voice to this urgent cause and help us call for a delay in the Mounjaro price increase by signing this petition.